Biosimilars: From Science to Practice in Cancer Care – UCL

Access the course here: https://www.ucl.ac.uk/pharmacy/study/professional-development/biosimilars-science-practice-cancer-care

In this expert authored eLearning module, our team at UCL School of Pharmacy, collaborating with pharmacists at University College London and The Royal Marsden Hospital, will take you through the scientific knowledge needed in the adoption of biosimilar medicines.

Learning objectives

On completion of the eLearning module, you will be able to:

  • Demonstrate your understanding of the difference between biologic and chemical drugs.
  • Improve your understanding of biosimilars vs generics in terms of characteristics of structure and the clinical trials required.
  • Demonstrate knowledge of comparability studies and regulatory data.
  • Improve knowledge of practical aspects of adopting biosimilars – storage and stability differences.
  • Show understanding of patient considerations eg. revised consent, adverse reactions and patient information.
  • Improve confidence in handling clinician concerns prior to uptake.

Join this course

The course is free to access. Please click here to enrol. You will be taken to a webpage where you need to click ‘Select’. After this you will need to log in if you have a UCL Extend Account, or create a new account.

If you have any queries about the course please contact Pinkie Chambers at [email protected]

Follow the Twitter handle @UCLbiosimilar to join in with the discussion, ask questions and stay up to date with recent developments.

Latest News

By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article
By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article